(Q43724403)

26 November 2017

title

Achieving and maintaining National Cholesterol Education Program low-density lipoprotein cholesterol goals with five statins (English)

1 reference

26 November 2017

1 reference

Andrews TC

1

1 reference

26 November 2017

Ballantyne CM

series ordinal

2

1 reference

26 November 2017

Hsia JA

series ordinal

3

1 reference

26 November 2017

Kramer JH

series ordinal

4

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

American Journal of Medicine

26 November 2017

published in

1 reference

26 November 2017

volume

111

1 reference

26 November 2017

issue

3

1 reference

26 November 2017

page(s)

185-191

1 reference

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900799-9

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900799-9

Physician noncompliance with the 1993 National Cholesterol Education Program (NCEP-ATPII) guidelines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900799-9

The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900799-9

Inadequate treatment with HMG-CoA reductase inhibitors by health care providers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900799-9

Drug therapy for hypercholesterolemia in patients with cardiovascular disease: factors limiting achievement of lipid goals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900799-9

Adherence to National Cholesterol Education Program Treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS). The HERS Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900799-9

Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Post CABG Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900799-9

The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900799-9

Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900799-9

Efficacy and safety of simvastatin 80 mg/day in hypercholesterolemic patients. The Expanded Dose Simvastatin U.S. Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900799-9

10.1016/S0002-9343(01)00799-9

7 January 2021

Identifiers

DOI

1 reference

26 November 2017

1 reference